New aquaculture joint venture wants to replace antibiotic use with probiotics technology

The manufacturing facility is anticipated to begin operations early 2025.

"This partnership positions us to provide probiotics and enzymes to meet the surging global demand," Blue Aqua CEO and founder Farshad Shishehchian said.
"This partnership positions us to provide probiotics and enzymes to meet the surging global demand," Blue Aqua CEO and founder Farshad Shishehchian said.Photo: AIChe
Published 15 November 2023, 05:01Updated 15 November 2023, 05:01